{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:33:51Z","timestamp":1773063231091,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,8,7]],"date-time":"2009-08-07T00:00:00Z","timestamp":1249603200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s12185-009-0387-1","type":"journal-article","created":{"date-parts":[[2009,8,6]],"date-time":"2009-08-06T06:10:37Z","timestamp":1249539037000},"page":"174-176","source":"Crossref","is-referenced-by-count":14,"title":["Successful treatment with rituximab of refractory idiopathic thrombocytopenic purpura in a patient with Kabuki syndrome"],"prefix":"10.1007","volume":"90","author":[{"given":"Yuka","family":"Torii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yagasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asahito","family":"Hama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,7]]},"reference":[{"key":"387_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0022-3476(81)80255-7","volume":"99","author":"N Niikawa","year":"1981","unstructured":"Niikawa N, Matsuura N, Fukushima Y, et al. Kabuki make-up syndrome: a syndrome of mental retardation, unusual faces, large end protruding ears, and postnatal growth deficiency. J Pediatr. 1981;99:565\u20139.","journal-title":"J Pediatr"},{"key":"387_CR2","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/S0022-3476(81)80256-9","volume":"99","author":"Y Kuroki","year":"1981","unstructured":"Kuroki Y, Suzuki Y, Chyo H, et al. A new malformation syndrome of long palpebral fissures, large ears, depressed nasal tip, and skeletal anomalies associated with postnatal dwarfism and mental retardation. J Pediatr. 1981;99:570\u20133.","journal-title":"J Pediatr"},{"key":"387_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/ajmg.1320310312","volume":"31","author":"N Niikawa","year":"1988","unstructured":"Niikawa N, Kuroki Y, Kajii T, et al. Kabuki make-up (Niikawa\u2013Kuroki) syndrome: a study of 62 patients. Am J Med Genet. 1988;31:565\u201389.","journal-title":"Am J Med Genet"},{"key":"387_CR4","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S0022-3476(99)70207-6","volume":"134","author":"H Kawame","year":"1999","unstructured":"Kawame H, Hannibal MC, Hudgins L, et al. Phenotypic spectrum and management issues in Kabuki syndromes. J Pediatr. 1999;134:480\u20135.","journal-title":"J Pediatr"},{"key":"387_CR5","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ajmg.a.30722","volume":"135A","author":"JD Hoffman","year":"2005","unstructured":"Hoffman JD, Ciprero KL, Sullivan KE, et al. Immune abnormalities are a frequent manifestation of Kabuki syndrome. Am J Med Genet. 2005;135A:278\u201381.","journal-title":"Am J Med Genet"},{"key":"387_CR6","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/ajmg.a.30332","volume":"132A","author":"JE Ming","year":"2005","unstructured":"Ming JE, Russell KL, McDonald-McGinn DM, et al. Autoimmune disorders in Kabuki syndrome. Am J Med Genet. 2005;132A:260\u20132.","journal-title":"Am J Med Genet"},{"key":"387_CR7","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1182\/blood.V98.4.952","volume":"98","author":"R Stasi","year":"2001","unstructured":"Stasi R, Pagano A, Stipa E, et al. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood. 2001;98:952\u20137.","journal-title":"Blood"},{"key":"387_CR8","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1182\/blood-2005-08-3518","volume":"107","author":"CM Bennett","year":"2006","unstructured":"Bennett CM, Rogers ZR, Kinnamon DD, et al. Prospective phase 1\/2 study of rituximab in children and adolescent chronic immune thrombocytopenic purpura. Blood. 2006;107:2639\u201342.","journal-title":"Blood"},{"key":"387_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jpeds.2004.09.004","volume":"146","author":"J Wang","year":"2005","unstructured":"Wang J, Wiley JM, Luddy R, et al. Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatment. J Pediatr. 2005;146:217\u201321.","journal-title":"J Pediatr"},{"key":"387_CR10","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3324\/haematol.12206","volume":"93","author":"F Zaja","year":"2008","unstructured":"Zaja F, Battista ML, Pirrotta MT, et al. Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura. Hematologica. 2008;93:930\u20133.","journal-title":"Hematologica"},{"key":"387_CR11","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.3324\/haematol.11709","volume":"92","author":"D Provan","year":"2007","unstructured":"Provan D, Butler T, Evangelista ML, et al. Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults. Haemotologica. 2007;92:1695\u20138.","journal-title":"Haemotologica"},{"key":"387_CR12","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1182\/blood-2002-02-0392","volume":"99","author":"R Stasi","year":"2002","unstructured":"Stasi R, Stipa E, Forte V, et al. Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura. Blood. 2002;99:3872\u20133.","journal-title":"Blood"},{"key":"387_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/ncprheum0424","volume":"3","author":"RP Taylor","year":"2007","unstructured":"Taylor RP, Lindorfer MA. Drug insight: the mechanism of action of rituximab in autoimmune disease: the immune complex decoy hypothesis. Nat Clin Pract Rheumatol. 2007;3:86\u201395.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"387_CR14","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/nm921","volume":"9","author":"B Olsson","year":"2003","unstructured":"Olsson B, Andersson PO, Jern\u00e5s M, et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med. 2003;9:1123\u20134.","journal-title":"Nat Med"},{"key":"387_CR15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/rheumatology\/keh443","volume":"44","author":"M Tokunaga","year":"2005","unstructured":"Tokunaga M, Fujii K, Saito K, et al. Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab. Rheumatology. 2005;44:176\u201382.","journal-title":"Rheumatology"},{"key":"387_CR16","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1182\/blood-2007-02-068999","volume":"110","author":"R Stasi","year":"2007","unstructured":"Stasi R, Del Poeta G, Stipa E, et al. Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura. Blood. 2007;110:2924\u201330.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0387-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-009-0387-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0387-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0387-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T05:01:27Z","timestamp":1559451687000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-009-0387-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,7]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["387"],"URL":"https:\/\/doi.org\/10.1007\/s12185-009-0387-1","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,7]]}}}